High-quality development of subnational cancer prevention and control: investigation and experiences_West China Medical Journal

Authors：

LEI Kaijian ¹ , YU Lili ² , LI Zikang ³ ,  CHEN Xinzu ^1,3,4,5 , SIGES Research Group ⁵

1. Yibin Cancer Prevention and Control Center, the Second People’s Hospital of Yibin (West China Yibin Hospital, Sichuan University), Yibin, Sichuan 644000, P. R. China;
2. Yibin Center for Disease Control and Prevention, Yibin, Sichuan 644000, P. R. China;
3. Ya’an Cancer Prevention and Control Center, Ya’an People’s Hospital (West China Ya’an Hospital, Sichuan University), Ya’an, Sichuan 625000, P. R. China;
4. Ya’an Key Laboratory for High Altitude Medicine, Ya’an People’s Hospital (West China Ya’an Hospital, Sichuan University), Ya’an, Sichuan 625000, P. R. China;
5. Gastric Cancer Center, Department of General Surgery, West China Hospital, Sichuan University, Chengdu, Sichuan 610041, P. R. China;

Corresponding?author：

CHEN Xinzu, Email: chenxinzu@scu.edu.cn

Keywords：

Healthy China 2030; high-quality development; cancer prevention and control; public health; clinical epidemiology

DOI：

10.7507/1002-0179.202407307

Video：

Export PDF Favorites Scan Get Citation

Abstract Full text Figures/Tables Video References Cited by

Cancer prevention and control is an important healthcare task towards major diseases of the Chinese people and an important part of the “Healthy China 2030” plan outline. This article summarizes and introduces the current status and practical experience of subnational cancer prevention and treatment status in Yibin City and Ya’an City of Sichuan Province. Lung cancer, digestive system cancers, and cervical and breast cancers compose of the majority of cancers with high incidence. In the aspect of cancer epidemiology, there are certain disparities among cities and between urban and rural areas, among which the mortality risk of cancer in rural areas is higher. In Yibin and Ya’an cities, the specialized agencies and governance system for subnational cancer prevention and control are still in the early stage of development, and the background data such as cancer-specific survival rate, public awareness of core knowledge on cancer prevention and control, quality control of key techniques, and healthcare resources in subnational areas are still unclear. Therefore, all levels of cancer prevention and control need further strengthening the organizational leadership and system construction, and promoting the hierarchic healthcare and balanced development.

Citation： LEI Kaijian, YU Lili, LI Zikang, CHEN Xinzu, SIGES Research Group. High-quality development of subnational cancer prevention and control: investigation and experiences. West China Medical Journal, 2024, 39(12): 1948-1952. doi: 10.7507/1002-0179.202407307 Copy

1.	魏文強, 沈洪兵. 中國癌癥防控歷史、現狀與展望. 中華疾病控制雜志, 2019, 23(10): 1165-1168, 1180.
2.	李茁鈺, 劉凱, 張維漢, 等. 全球及中國胃癌的流行病學特點及趨勢:2018–2022《全球癌癥統計報告》解讀. 中國普外基礎與臨床雜志, 2024, 31(10): 1236-1245.
3.	Han B, Zheng R, Zeng H, et al. Cancer incidence and mortality in China, 2022. J Natl Cancer Cent, 2024, 4(1): 47-53.
4.	Cao W, Chen HD, Yu YW, et al. Changing profiles of cancer burden worldwide and in China: a secondary analysis of the global cancer statistics 2020. Chin Med J (Engl), 2021, 134(7): 783-791.
5.	曹巍, 胡瑩云, 陳萬青. 高質量推進癌癥綜合防治,有效降低癌癥疾病負擔. 中國腫瘤, 2024, 33(1): 1-5.
6.	新華社. 中共中央國務院印發《“健康中國 2030”規劃綱要》. 中華人民共和國國務院公報, 2016(32): 5-20.
7.	Zou JC, Yang Y, Chen XZ, et al. Active eradication of helicobacter pylori within organized massive screening might improve survival of gastric cancer patients. Gastroenterology, 2023, 164(1): 162-163.
8.	中華人民共和國國家衛生健康委員會醫療應急司. 健康中國行動——癌癥防治行動實施方案(2023-2030 年). 中國腫瘤, 2023, 32(12): 887-890.
9.	Qi J, Li M, Wang L, et al. National and subnational trends in cancer burden in China, 2005-20: an analysis of national mortality surveillance data. Lancet Public Health, 2023, 8(12): e943-e955.
10.	陳心足, 胡建昆, SIGES 研究組. 胃癌防控策略的探索與優化:流行病學、病原微生物及危險因素. 中國普外基礎與臨床雜志, 2023, 30(1): 86-90.
11.	Yang K, Choi YY, Zhang WH, et al. Strategies to improve treatment outcome in gastric cancer: a retrospective analysis of patients from two high-volume hospitals in Korea and China. Oncotarget, 2016, 7(28): 44660-44675.
12.	Zou JC, Wen MY, Huang Y, et al. Helicobacter pylori infection prevalence declined among an urban health check-up population in Chengdu, China: a longitudinal analysis of multiple cross-sectional studies. Front Public Health, 2023, 11: 1128765.
13.	Bai D, Liu K, Wang R, et al. Prevalence difference of helicobacter pylori infection between Tibetan and Han ethnics in China: a meta-analysis on epidemiologic studies (SIGES). Asia Pac J Public Health, 2023, 35(2-3): 103-111.
14.	Chen XZ, Hu JK, Zhou ZG. Importance of organized screening and surveillance for colorectal cancer in China: epidemiological differences from Europe. Eur J Cancer Prev, 2015, 24(6): 459-460.
15.	Gou HF, Liu Y, Yang TX, et al. Necessity of organized low-dose computed tomography screening for lung cancer: from epidemiologic comparisons between China and the Western nations. Oncotarget, 2017, 8(1): 1788-1795.
16.	陳萍, 傅曉花, 薛康, 等. 四川高海拔藏族居民癌癥防治知識知曉率及參與篩查情況分析. 現代腫瘤醫學, 2024, 32(9): 1709-1716.
17.	馬婧, 喬良, 鐘志剛, 等. 基于傾向性評分匹配的四川省居民癌癥防治核心知識知曉情況變化分析. 腫瘤預防與治療, 2024, 37(2): 140-148.
18.	Wang R, Bai D, Xiang W, et al. Tibetan ethnicity, birthplace, helicobacter pylori infection, and gastric cancer risk. Am J Gastroenterol, 2022, 117(6): 1010.
19.	Yu TH, Wang R, Chen XZ, et al. Multifactorial co-exposure within family of gastric cancer: increased risk of familial gastric cancer and tailored prevention. Med Oncol, 2022, 40(1): 19.
20.	崔娟, 趙一凡, 范雷, 等. 鄉村醫生癌癥防治知識干預效果評價. 中國公共衛生管理, 2015, 31(4): 513-514.
21.	四川省衛生健康委員會. 全力推進“健康四川”行動,探索建立“四川癌防模式”. 健康中國觀察, 2023(12): 24-26.
22.	Chen XC, Chen XZ. Epidemiological differences in haematological malignancies between Europe and China. Lancet Oncol, 2014, 15(11): e471-472.
23.	王淼, 石柯燦, 陳蕾, 等. 四川大學華西醫院領辦型緊密醫療聯合體特征分析. 華西醫學, 2019, 34(12): 1422-1425.
24.	陳心足, 羅英, 夏一尹, 等. 宜賓市“省-市-縣-鄉”四級分級診療體系建設的初步探索. 華西醫學, 2021, 36(7): 949-953.
25.	董家鴻, 張宗久. 中國整合式衛生醫護體系發展報告(2023). 北京: 社會科學文獻出版社, 2024: 1.
26.	中華人民共和國國家衛生健康委員會. 關于印發“十四五”全民健康信息化規劃的通知. 中華人民共和國國家衛生健康委員會公報, 2022(11): 7-18.
27.	《中國衛生信息管理雜志》編委會. 以人民健康為中心推動“十四五”全民健康信息化規劃落地實施. 中國衛生信息管理雜志, 2023, 20(1): 5.
28.	陳嘉莉, 馬自強, 蘭亞杰, 等. 基于區塊鏈技術的醫療信息共享研究綜述. 計算機應用研究, 2024, 41(9): 2573-2584.
29.	俞思偉, 傅馬, 馮露漪, 等. 衛生健康領域區塊鏈應用現狀研究與趨勢分析. 中國數字醫學, 2024, 19(1): 1-6.
30.	朱春倫, 唐玲, 邵維君, 等. 基于區塊鏈的異地醫療信息共享試點項目實踐. 中國數字醫學, 2024, 19(1): 29-33.

1. 魏文強, 沈洪兵. 中國癌癥防控歷史、現狀與展望. 中華疾病控制雜志, 2019, 23(10): 1165-1168, 1180.
2. 李茁鈺, 劉凱, 張維漢, 等. 全球及中國胃癌的流行病學特點及趨勢:2018–2022《全球癌癥統計報告》解讀. 中國普外基礎與臨床雜志, 2024, 31(10): 1236-1245.
3. Han B, Zheng R, Zeng H, et al. Cancer incidence and mortality in China, 2022. J Natl Cancer Cent, 2024, 4(1): 47-53.
4. Cao W, Chen HD, Yu YW, et al. Changing profiles of cancer burden worldwide and in China: a secondary analysis of the global cancer statistics 2020. Chin Med J (Engl), 2021, 134(7): 783-791.
5. 曹巍, 胡瑩云, 陳萬青. 高質量推進癌癥綜合防治,有效降低癌癥疾病負擔. 中國腫瘤, 2024, 33(1): 1-5.
6. 新華社. 中共中央國務院印發《“健康中國 2030”規劃綱要》. 中華人民共和國國務院公報, 2016(32): 5-20.
7. Zou JC, Yang Y, Chen XZ, et al. Active eradication of helicobacter pylori within organized massive screening might improve survival of gastric cancer patients. Gastroenterology, 2023, 164(1): 162-163.
8. 中華人民共和國國家衛生健康委員會醫療應急司. 健康中國行動——癌癥防治行動實施方案(2023-2030 年). 中國腫瘤, 2023, 32(12): 887-890.
9. Qi J, Li M, Wang L, et al. National and subnational trends in cancer burden in China, 2005-20: an analysis of national mortality surveillance data. Lancet Public Health, 2023, 8(12): e943-e955.
10. 陳心足, 胡建昆, SIGES 研究組. 胃癌防控策略的探索與優化:流行病學、病原微生物及危險因素. 中國普外基礎與臨床雜志, 2023, 30(1): 86-90.
11. Yang K, Choi YY, Zhang WH, et al. Strategies to improve treatment outcome in gastric cancer: a retrospective analysis of patients from two high-volume hospitals in Korea and China. Oncotarget, 2016, 7(28): 44660-44675.
12. Zou JC, Wen MY, Huang Y, et al. Helicobacter pylori infection prevalence declined among an urban health check-up population in Chengdu, China: a longitudinal analysis of multiple cross-sectional studies. Front Public Health, 2023, 11: 1128765.
13. Bai D, Liu K, Wang R, et al. Prevalence difference of helicobacter pylori infection between Tibetan and Han ethnics in China: a meta-analysis on epidemiologic studies (SIGES). Asia Pac J Public Health, 2023, 35(2-3): 103-111.
14. Chen XZ, Hu JK, Zhou ZG. Importance of organized screening and surveillance for colorectal cancer in China: epidemiological differences from Europe. Eur J Cancer Prev, 2015, 24(6): 459-460.
15. Gou HF, Liu Y, Yang TX, et al. Necessity of organized low-dose computed tomography screening for lung cancer: from epidemiologic comparisons between China and the Western nations. Oncotarget, 2017, 8(1): 1788-1795.
16. 陳萍, 傅曉花, 薛康, 等. 四川高海拔藏族居民癌癥防治知識知曉率及參與篩查情況分析. 現代腫瘤醫學, 2024, 32(9): 1709-1716.
17. 馬婧, 喬良, 鐘志剛, 等. 基于傾向性評分匹配的四川省居民癌癥防治核心知識知曉情況變化分析. 腫瘤預防與治療, 2024, 37(2): 140-148.
18. Wang R, Bai D, Xiang W, et al. Tibetan ethnicity, birthplace, helicobacter pylori infection, and gastric cancer risk. Am J Gastroenterol, 2022, 117(6): 1010.
19. Yu TH, Wang R, Chen XZ, et al. Multifactorial co-exposure within family of gastric cancer: increased risk of familial gastric cancer and tailored prevention. Med Oncol, 2022, 40(1): 19.
20. 崔娟, 趙一凡, 范雷, 等. 鄉村醫生癌癥防治知識干預效果評價. 中國公共衛生管理, 2015, 31(4): 513-514.
21. 四川省衛生健康委員會. 全力推進“健康四川”行動,探索建立“四川癌防模式”. 健康中國觀察, 2023(12): 24-26.
22. Chen XC, Chen XZ. Epidemiological differences in haematological malignancies between Europe and China. Lancet Oncol, 2014, 15(11): e471-472.
23. 王淼, 石柯燦, 陳蕾, 等. 四川大學華西醫院領辦型緊密醫療聯合體特征分析. 華西醫學, 2019, 34(12): 1422-1425.
24. 陳心足, 羅英, 夏一尹, 等. 宜賓市“省-市-縣-鄉”四級分級診療體系建設的初步探索. 華西醫學, 2021, 36(7): 949-953.
25. 董家鴻, 張宗久. 中國整合式衛生醫護體系發展報告(2023). 北京: 社會科學文獻出版社, 2024: 1.
26. 中華人民共和國國家衛生健康委員會. 關于印發“十四五”全民健康信息化規劃的通知. 中華人民共和國國家衛生健康委員會公報, 2022(11): 7-18.
27. 《中國衛生信息管理雜志》編委會. 以人民健康為中心推動“十四五”全民健康信息化規劃落地實施. 中國衛生信息管理雜志, 2023, 20(1): 5.
28. 陳嘉莉, 馬自強, 蘭亞杰, 等. 基于區塊鏈技術的醫療信息共享研究綜述. 計算機應用研究, 2024, 41(9): 2573-2584.
29. 俞思偉, 傅馬, 馮露漪, 等. 衛生健康領域區塊鏈應用現狀研究與趨勢分析. 中國數字醫學, 2024, 19(1): 1-6.
30. 朱春倫, 唐玲, 邵維君, 等. 基于區塊鏈的異地醫療信息共享試點項目實踐. 中國數字醫學, 2024, 19(1): 29-33.

West China Medical Journal

High-quality development of subnational cancer prevention and control: investigation and experiences

Abstract Full text Figures/Tables Video References Cited by

Previous Article

Next Article

Format

Content